Registry randomised trials: a methodological perspective

BMJ Open. 2023 Mar 1;13(3):e068057. doi: 10.1136/bmjopen-2022-068057.

Abstract

Registry randomised clinical trials (RRCTs) have the potential to provide pragmatic answers to important clinical questions. RRCTs can be embedded into large population-based registries or smaller single site registries to provide timely answers at a reduced cost compared with traditional randomised controlled trials. RRCTs can take a number of forms in addition to the traditional individual-level randomised trial, including parallel group trials, platform or adaptive trials, cluster randomised trials and cluster randomised stepped-wedge trials. From an implementation perspective, initially it is advantageous to embed RRCT into well-established registries as these have typically already overcome any issues with end point validation and adjudication. With advances in data linkage and data quality, RRCTs can play an important role in answering clinical questions in a pragmatic, cost-effective way.

Keywords: biotechnology & bioinformatics; public health; statistics & research methods.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Data Accuracy*
  • Humans
  • Randomized Controlled Trials as Topic*
  • Registries*